As we approach results of our M-001 #UniversalFluVaccine Phase 3 trial in the coming months, join @BioJEP, our Director of BizDev & Investor Relations, for his presentation followed by Q&A this Wednesday.
[Note: Trial results expected no earlier than late Sept!]
#VaccineVirtual